Vimta Labs Limited (VIMTALABS) - Total Assets
Based on the latest financial reports, Vimta Labs Limited (VIMTALABS) holds total assets worth Rs5.18 Billion INR (≈ $56.04 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See VIMTALABS total equity for net asset value and shareholders' equity analysis.
Vimta Labs Limited - Total Assets Trend (2006–2025)
This chart illustrates how Vimta Labs Limited's total assets have evolved over time, based on quarterly financial data.
Vimta Labs Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Vimta Labs Limited's total assets of Rs5.18 Billion consist of 40.3% current assets and 59.7% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 3.4% |
| Accounts Receivable | Rs1.06 Billion | 22.8% |
| Inventory | Rs250.56 Million | 5.4% |
| Property, Plant & Equipment | Rs2.62 Billion | 56.1% |
| Intangible Assets | Rs64.19 Million | 1.4% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2006–2025)
This chart illustrates how Vimta Labs Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see VIMTALABS company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Vimta Labs Limited's current assets represent 40.3% of total assets in 2025, a decrease from 56.6% in 2006.
- Cash Position: Cash and equivalents constituted 3.4% of total assets in 2025, down from 4.2% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2006.
- Asset Diversification: The largest asset category is property, plant & equipment at 56.1% of total assets.
Vimta Labs Limited Competitors by Total Assets
Key competitors of Vimta Labs Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Clinica Baviera
MC:CBAV
|
Spain | €228.01 Million |
|
Centro de Imagem Diagnósticos S.A
SA:AALR3
|
Brazil | R$3.03 Billion |
|
Inoviq Ltd
AU:IIQ
|
Australia | AU$24.52 Million |
|
Predilife
PA:ALPRE
|
France | €1.31 Million |
|
Imagion Biosystems Ltd
AU:IBX
|
Australia | AU$932.48K |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
Vimta Labs Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.30 | 2.22 | 1.85 |
| Quick Ratio | 2.85 | 1.88 | 1.57 |
| Cash Ratio | 0.85 | 0.36 | 0.00 |
| Working Capital | Rs1.48 Billion | Rs946.40 Million | Rs450.42 Million |
Vimta Labs Limited - Advanced Valuation Insights
This section examines the relationship between Vimta Labs Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.01 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | 16.6% |
| Total Assets | Rs4.67 Billion |
| Market Capitalization | $247.25 Million USD |
Valuation Analysis
Below Book Valuation: The market values Vimta Labs Limited's assets below their book value (0.05x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Vimta Labs Limited's assets grew by 16.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Vimta Labs Limited (2006–2025)
The table below shows the annual total assets of Vimta Labs Limited from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs4.67 Billion ≈ $50.45 Million |
+16.62% |
| 2024-03-31 | Rs4.00 Billion ≈ $43.26 Million |
+10.41% |
| 2023-03-31 | Rs3.62 Billion ≈ $39.18 Million |
+17.95% |
| 2022-03-31 | Rs3.07 Billion ≈ $33.22 Million |
+11.97% |
| 2021-03-31 | Rs2.74 Billion ≈ $29.67 Million |
+11.63% |
| 2020-03-31 | Rs2.46 Billion ≈ $26.58 Million |
+3.51% |
| 2019-03-31 | Rs2.37 Billion ≈ $25.68 Million |
+2.23% |
| 2018-03-31 | Rs2.32 Billion ≈ $25.12 Million |
+4.79% |
| 2017-03-31 | Rs2.22 Billion ≈ $23.97 Million |
+26.22% |
| 2016-03-31 | Rs1.76 Billion ≈ $18.99 Million |
+19.99% |
| 2015-03-31 | Rs1.46 Billion ≈ $15.83 Million |
-1.80% |
| 2014-03-31 | Rs1.49 Billion ≈ $16.12 Million |
+3.06% |
| 2013-03-31 | Rs1.45 Billion ≈ $15.64 Million |
-7.56% |
| 2012-03-31 | Rs1.56 Billion ≈ $16.92 Million |
-11.39% |
| 2011-03-31 | Rs1.77 Billion ≈ $19.09 Million |
-2.92% |
| 2010-03-31 | Rs1.82 Billion ≈ $19.67 Million |
+7.09% |
| 2009-03-31 | Rs1.70 Billion ≈ $18.36 Million |
-1.59% |
| 2008-03-31 | Rs1.73 Billion ≈ $18.66 Million |
-0.78% |
| 2007-03-31 | Rs1.74 Billion ≈ $18.81 Million |
+1.81% |
| 2006-03-31 | Rs1.71 Billion ≈ $18.47 Million |
-- |
About Vimta Labs Limited
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract researc… Read more